Statistics for Baseline susceptibility of primary HIV-2 to entry inhibitors
Total visits
| views | |
|---|---|
| Baseline susceptibility of primary HIV-2 to entry inhibitors | 236 |
Total visits per month
| views | |
|---|---|
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
File Visits
| views | |
|---|---|
| Borrego et al Antiviral Therapy 2011.pdf | 321 |
| NeD78_RaulFrancoisMartins.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 91 |
| Portugal | 36 |
| Germany | 28 |
| France | 13 |
| China | 11 |
| Russia | 8 |
| Poland | 4 |
| United Kingdom | 3 |
| India | 3 |
| Luxembourg | 3 |
| Ukraine | 3 |
| Brazil | 2 |
| Saudi Arabia | 2 |
| Turkey | 2 |
| United Arab Emirates | 1 |
| Angola | 1 |
| Australia | 1 |
| Canada | 1 |
| Switzerland | 1 |
| Côte d’Ivoire | 1 |
| Curaçao | 1 |
| Denmark | 1 |
| Spain | 1 |
| Hong Kong SAR China | 1 |
| Indonesia | 1 |
| Ireland | 1 |
| Japan | 1 |
| Mozambique | 1 |
| Netherlands | 1 |
| Sweden | 1 |
| Slovenia | 1 |
| Thailand | 1 |
| Tunisia | 1 |
| South Africa | 1 |